Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06743646 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 17, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 8 of 8 sites
    • Publications: 2 to 5
    v3
  2. Start date changed from estimate of Dec 30, 2024 to Dec 27, 2024v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multi-center, randomized and controlled phase 3 clinical trial.
Trial Details
NCT Number NCT06743646
Lead Sponsor Chigenovo Co., Ltd
Conditions
(from sponsor)		 Bietti Crystalline Corneoretinal Dystrophy, Bietti Crystalline Dystrophy
Related terms Bietti Crystalline Dystrophy
Enrollment 62 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov